Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenious Yeast Tablets in Early CLL
NCT05136378Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of selenium yeast in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) (3 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Disease Progression Rate at 2 years and Decrease rate of Lymphocyte at 2 years. Started Nov 2021; status: recruiting.
02
Drugs
selenium yeast
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT05136378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136378.